Organization
Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele
1 abstract
Abstract
BELLWAVE-010: A phase 3 study of nemtabrutinib plus venetoclax versus venetoclax plus rituximab (VR) in previously treated patients (pts) with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).Org: Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele,